The ATS 2023 International Conference offers a robust scientific program highlighting the cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several sessions addressing new developments and considerations in interstitial lung disease and idiopathic pulmonary fibrosis, as listed below. A curated list of clinical and scientific sessions related to these topics also is available on the conference website. For more information on these and other sessions to be presented May 19–24 in Washington, DC, visit the online Program Itinerary.
- A1. Clinical Year in Review 1
- A88. Neuro-Immune Interactions in Lung Development and Disease
- B12. ATS Clinical Practice Guidelines: Clinical Practice on the Cutting Edge
- B82. The Genetics of Interstitial Lung Disease: Current State and Future Promise
- C2. Endpoints for Therapeutic Trials in ILD
- C83. Pro/Con: Hot Topics in Interstitial Lung Disease
- C86. Beyond the Transcriptome: How The Multi-“Omic” Universe Provides Novel Insights into IPF/ILD Pathogenesis
- D2. Cough in Pulmonary Fibrosis — Annoying Symptom or Driver/Marker of Disease Progression?
REGISTER FOR ATS 2024
Register today for the ATS 2024 International Conference! Don’t miss this opportunity to take part in the in-person conference, May 17-22 in San Diego. Join your colleagues to learn about the latest developments in pulmonary, critical care, and sleep medicine.
Not an ATS member? Join today and save up to $540.